Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ACI FormulationsDHA:ACIFORMULA +1.42%88 Altman Z2-Score is 2.77 as of Jul. 28, 2026, which is 2% above its 10-year median of 2.72. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 88/100 and a GF Value™ of BDT149.51 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 255 Agriculture companies, ACI Formulations ranks worse than 63.92% on this metric.
Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.
Good Sign:
ACI Formulations has a Altman Z2-Score of 2.77, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.
The zones of discrimination were as such:
When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.
The historical rank and industry rank for ACI Formulations's Altman Z2-Score or its related term are showing as below:
DHA:ACIFORMULA'
s Altman Z2-Score Range Over the Past 10 Years
Min: 1.97 Med: 2.72 Max: 3.22
Current: 2.77
During the past 13 years, ACI Formulations's highest Altman Z2-Score was 3.22. The lowest was 1.97. And the median was 2.72.
The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
Altman Z2-Score does not apply to financial companies.
ACI Formulations Altman Z2-Score Related Terms
ACI Formulations Altman Z2-Score Historical Data
* Premium members only.
The historical data trend for ACI Formulations's Altman Z2-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACIFORMULA vs CTVA, CF, MOS: Altman Z2-Score Comparison
For the Agricultural Inputs subindustry, ACI Formulations's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACI Formulations Altman Z2-Score vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, ACI Formulations's Altman Z2-Score distribution charts can be found below:
* The bar in red indicates where ACI Formulations's Altman Z2-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.
ACI Formulations's Altman Z2-Score for today is calculated with this formula:
Z
=
6.56
*
X1
+
3.26
*
X2
+
6.72
*
X3
+
1.05
*
X4_2
=
6.56
*
0.1324
+
3.26
*
0.202
+
6.72
*
0.076
+
1.05
*
0.6957
=
2.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.
ACI Formulations (DHA:ACIFORMULA) has a Altman Z2-Score of 2.77 as of Jul. 28, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on ACI Formulations and its competitors. This is near median its historical median of 2.72. Over the past decade, ACI Formulations' Altman Z2-Score has ranged from 1.97 to 3.22. According to the industry distribution chart, ACI Formulations ranks #163 out of 255 companies in the Agriculture industry, placing it in the top 63.9%.
Is ACI Formulations' Altman Z2-Score too high?
ACI Formulations' current Altman Z2-Score of 2.77 is near median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 1.97 to a high of 3.22. The Agriculture industry median Altman Z2-Score is 3.52. ACI Formulations' value of 2.77 is 21.3% below this industry median. Based on the distribution chart, ACI Formulations ranks #163 out of 255 companies in the Agriculture industry, which is below the industry midpoint. Overall, ACI Formulations has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Altman Z2-Score compare to CTVA and CF?
According to the Agriculture industry distribution chart, ACI Formulations ranks #163 out of 255 companies for Altman Z2-Score. This places ACI Formulations in the lower half of its industry. The industry median Altman Z2-Score is 3.52. ACI Formulations' value of 2.77 is 21.3% below this benchmark. Historically, ACI Formulations' own Altman Z2-Score has ranged from 1.97 to 3.22 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 3.52, ACI Formulations has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for an Agriculture company?
The median Altman Z2-Score among Agriculture companies is 3.52, based on 255 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACI Formulations's current Altman Z2-Score of 2.77 is 21.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on ACI Formulations and its competitors. For the Agriculture industry, the median Altman Z2-Score is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACI Formulations's current Altman Z2-Score is 2.77, which is near median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT149.51, compared to a current price of BDT172.00 — trading 15% above its estimated fair value. The current Altman Z2-Score is 2.77, which is near median its 10-year median of 2.72 and 21.3% below the Agriculture industry median of 3.52. ACI Formulations' overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Altman Z2-Score is 2.77 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?
Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued.
The current stock price of BDT172.00 is trading 15% above its estimated GF Value™ of BDT149.51.
GuruFocus considers ACI Formulations to be Modestly Overvalued.
Key valuation signals for DHA:ACIFORMULA:
Altman Z2-Score: 2.77 (near median its 10-year median of 2.72)
GF Value™: BDT149.51 vs. price of BDT172.00 (15% above fair value)
Industry Position: 21.3% below the Agriculture median (#163 of 255)
No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score
Get the complete analysis for DHA:ACIFORMULA
Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACIFORMULA has been successfully added to your 
